论文部分内容阅读
为了验证NT-O-BSA为抗原的间接酶联免疫试验(以下简称ELISA)和NT-P-BSA抗原致敏明胶颗粒的间接凝集试验(以下简称GPAT)方法及其在免疫流行病学调查方面的现场应用,我们采用上述两法测定了贵州省11县1693例麻风病人接触者血清酚糖脂抗体—I(PGI),现将测定结果和初步分析作以下报告。
In order to validate the indirect agglutination test (hereinafter referred to as GPAT) of NT-O-BSA antigen indirect immunosorbent assay (hereinafter referred to as ELISA) and NT-P-BSA antigen sensitized gelatin particles and its application in immune epidemiological investigation Of the field applications, we use the above two methods to determine the contact count of 1693 cases of leprosy patients in 11 counties in Guizhou Province, serum phenol-lipopolyseril antibody-I (PGI), the results of the measurement and the preliminary analysis for the following report.